1
Clinical Trials associated with 68Ga-NOTA-PEG2-RM2668Ga-NOTA-PEG2-RM26 PET/CT: Tracer Biodistribution and Uptake in Different Kinds of Cancer With Gastrin-Releasing Peptide Receptor (GRPR) Overexpression
This is an open-label positron emission tomography/computed tomography (PET/CT) study to investigate the diagnostic performance and evaluation efficacy of 68Ga-NOTA-PEG2-RM26 in prostate cancer patients. A single dose of 2 MBq/kg of 68Ga-NOTA-PEG2-RM26 limited to 100-200 MBq per examination will be given intravenously. Visual and semiquantitative method will be used to assess PET/CT images.
100 Clinical Results associated with 68Ga-NOTA-PEG2-RM26
100 Translational Medicine associated with 68Ga-NOTA-PEG2-RM26
100 Patents (Medical) associated with 68Ga-NOTA-PEG2-RM26
100 Deals associated with 68Ga-NOTA-PEG2-RM26